CD274 and cancer: One important motivation is that many current biomarkers used as surrogates for inflamed tumours, such as TMB, neoantigen load and PD-L1 transcript expression [25, 58, 59] have limited applicability in the paediatric setting, where mutation burdens and neoantigen abundance are far lower than in most adult cancers [26].